Singapore-based healthtech startup Neurowyzr has allotted shares worth $2.24 million to investors, including Peak XV Partners (formerly known as Sequoia Capital India) and Apollo Hospitals Singapore.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
